Risk factors for depression in asthmatic individuals: Findings from NHANES (2005–2018)

Abstract

Background

The risk factors for depression in asthma are still unclear. The objective of this study was to identify the risk factors associated with depression in asthmatic individuals.

Methods

We used data from the 2005–2018 National Health and Nutrition Examination Survey (NHANES). Univariate analysis and multivariate logistic regression analyses were used to identify risk factors for depression and calculate unadjusted and adjusted odds ratios (ORs) and 95% confidence intervals (CIs).

Results

A total of 5,379 asthmatic participants were included. Of these subjects, 767 individuals had depression, and 4,612 individuals had no depression. Univariate analysis and multivariate analyses suggested that asthmatic individuals with smoking (OR 1.98, 95% CI 1.19–3.29), hypertension (OR 2.73, 95% CI 1.48–5.04), and arthritis (OR 2.83, 95% CI 1.53–5.22) were more likely to have depression. Asthmatic individuals who had more than a high school education had lower depression risk than those with less than a high school education (OR 0.55, 95% CI 0.30–0.99). Increasing age was also associated with decreased depression risk (OR 0.97, 95% CI 0.95–0.99).

Conclusions

Depression was more likely in asthmatic individuals with smoking, hypertension, and arthritis and less likely in individuals with higher education and increasing age. These findings could improve the identification of target populations for effective interventions to improve the mental health of asthmatic individuals.

Introduction

Asthma is a complex chronic inflammatory disorder of the conducting airways characterized by bronchial hyper-responsiveness and variable airflow obstruction [1]. It affects about 20 million individuals in the United States and over 300 million individuals worldwide and accounts for 1 in every 250 deaths in the world [2]. The cost of asthma management is $USD 1,900 in Europe and $USD 3,100 in the United States per person per year, indicating that asthma is associated with a significant economic and social burden [3].

Asthmatic individuals frequently had comorbidities, such as psychiatric symptoms and mental disorders [4]. Epidemiological studies showed that about 5% of adults worldwide suffer from depression [5], but this value for asthmatic individuals was more than 10% [6, 7]. Asthmatic individuals with depression were associated with a decreased level of asthma control and poor quality of life compared to those without depression [8, 9]. Treating depression had been shown to improve asthma control, corticosteroid use, and asthma exacerbations [10]. Therefore, it is necessary to identify and treat depression in asthmatic individuals.

Knowing the risk factors related to depression in asthmatic patients will help physicians recognize and intervene early in depression. However, to our best knowledge, there are no studies that have explored the risk factors for depression in asthmatic individuals. The risk factors of depression in asthma are still unclear. The objective of this study was to identify the risk factors (including modifiable factors) associated with depression in asthmatic individuals using a nationally representative sample from the National Health and Nutrition Examination Survey (NHANES).

Methods

Study population

The NHANES, conducted by the National Center for Health Statistics (NCHS) of the Centers for Disease Control and Prevention (CDC), was a nationally representative survey assessing the health and nutritional status of the U.S. civilian population [11]. NHANES data was based on household interviews and standardized physical examinations of survey participants. Each participant was weighted based on the portion of the US population that the individual represents. The protocol of NHANES was approved by the NCHS Institutional Review Board, and written informed consent was obtained from all participants.

For this study, we included data from NHANES participants from 2005 to 2018. Participants were excluded from analyses if they were without asthma or with missing information on the diagnosis of depression. Asthma relied on self-reporting of a doctor’s diagnosis. Participants were asked the questions: “Has a doctor ever told you that you have asthma?” together with “Do you still have asthma?” in interviews. In this study, asthma was defined by an affirmative answer to both questions [12].

Covariates’ assessment

Information on age, sex, race, weight, height, education, smoking status, and drinking status was obtained by self-reported. Participants were asked the question “Do you now smoke cigarettes”. Participants who selected either “every day” or “some days” were defined as smokers. Participants who reported “not at all” were defined as nonsmokers. Drinking was defined by using the question “Had at least 12 alcohol drinks/lifetime?”. Participants who reported “yes” were defined as drinkers. Participants who responded with “no” were defined as nondrinkers. Comorbidities relied on self-reporting of a doctor’s diagnosis. Hypertension, diabetes mellitus, coronary heart disease, congestive heart failure, stroke, arthritis, emphysema, chronic bronchitis, and cancer were included as covariates in that they had been found to be associated with depression.

Depression assessment

In NHANES 2005–2018, the Patient Health Questionnaire-9 (PHQ-9), a nine-item depression screening instrument, was used to measure depression symptoms over the past 2 weeks. The questions were asked at the Mobile Examination Center by trained interviewers. Each instrument was given a point ranging from 0 to 3 based on the response categories "not at all," "several days," "more than half the days," and "nearly every day.” Total PHQ-9 score ranges from 0 to 27 and ≥ 10 was regarded as depression [13]. Data from participants ≥18 years were included in the online data file (Depression Screener (DPQ_J)), so all eligible participants in this study were 18 years or older.

Statistical methods

The Baseline clinical characteristics of participants were described according to depression status. Continuous variables were described using weighted means and standard deviations and analyzed using weighted linear regression models. Categorical variables were described using weighted percentages and analyzed using weighted chi-square tests. Univariate analysis and multivariate logistic regression analysis were used to identify risk factors for depression and calculate unadjusted and adjusted odds ratios (ORs) and 95% confidence intervals (CIs). Age, gender, race, body mass index (BMI), education, cigarette smoking, drinking, hypertension, diabetes mellitus, coronary heart disease, congestive heart failure, stroke, arthritis, emphysema, chronic bronchitis, and cancer were included in both univariate analysis and multivariate logistic regression. All statistical analyses were done using EmpowerStats statistical software 2.0 (http://www.empowerstats.com, X&Y Solutions, Inc., Boston, MA) and Stata MP 14.0 with appropriate sampling weights. A two-tailed P value <0.05 was considered statistically significant.

Results

Participant characteristics

During the 2005~2018 NHANES cycles, 70,190 participants were interviewed. We excluded participants without asthma (60,211) and with missing information on the diagnosis of depression (4,600). Finally, a total of 5,379 asthmatic participants were included. Of these subjects, 767 individuals had depression, and 4,612 individuals had no depression. There are significant differences between subjects with and without depression (Table 1).

[Figure omitted. See PDF.]

Depression risk

In univariable logistic analyses (Table 2), the likelihood of depression was highest in females, Other Hispanic, and individuals with increasing age, obesity, less than high school education, current smoking, hypertension, diabetes mellitus, coronary heart disease, congestive heart failure, stroke, arthritis, emphysema, and chronic bronchitis. Further multivariable analyses confirmed that asthmatic individuals with smoking (OR 1.98, 95% CI 1.19–3.29), hypertension (OR 2.73, 95% CI 1.48–5.04), and arthritis (OR 2.83, 95% CI 1.53–5.22) were more likely to have depression (Table 3). Asthmatic individuals who have more than a high school education had lower depression risk than those with less than a high school education (OR 0.55, 95% CI 0.30–0.99). Increasing age was also associated with decreased depression risk in asthmatic individuals (OR 0.97, 95% CI 0.95–0.99).

[Figure omitted. See PDF.]

[Figure omitted. See PDF.]

Discussion

This study investigated the risk factors for depression in asthmatic individuals in a nationally representative sample of the U.S. population. The results showed that depression was more likely in asthmatic individuals with smoking, hypertension, and arthritis. Asthmatic individuals with higher education and increasing age were less likely to have depression.

Cigarette smoking remained one of the most important public health problems in the world, with heavy social, functional, and economic burdens [14, 15]. There was increasing evidence to suggest that smoking was associated with an increased risk of mental illnesses such as depression and anxiety [16]. Structural brain changes, inflammation and immune activation, increased oxidative and nitrosative stress, mitochondrial dysfunction, neurotransmitter systems and epigenetic alterations in smokers might have a role in the development of depression [17]. Asthma itself might contribute to a greater risk for depression and smoking would further increase the risk of depression in asthmatic individuals [18]. Asthmatic individuals should be earnestly advised not to start smoking [19]. McClave AK, et al. revealed that smoking cessation might alleviate depressive symptoms and reduce the incidence of depression [20], but a lot of studies found that quitting smoking would lead to increased depression and anxiety due to the withdrawal of nicotine [21]. Therefore, smoking cessation among asthmatic smokers should be under the guidance of doctors to avoid the withdrawal of nicotine.

In the present study, the incidence of depression was 14.2% in total asthmatic participants, whereas the incidence of depression increased to 19.9% in participants with asthma and hypertension. There was increasing evidence suggesting that there was a positive association between depression and hypertension. García-Fabela L, et al. found that hypertension was an independent predictor of depression among community-dwelling elders (adjusted OR 1.18; 95% CI,1.01–1.40) [22]. Meng, Lin, et al. found that depression increased the risk of hypertension (adjusted relative risk 1.42, 95% CI,1.09–1.86) [23]. Hypertension and depression had many common biological characteristics, such as systemic inflammation, metabolic syndrome, and dysregulation of the hypothalamic–pituitary–adrenal axis [24, 25]. Therefore, hypertension and depression might be risk factors for each other [23]. Asthmatic individuals with comorbid hypertension were associated with worse asthma control and better control of blood pressure might alleviate asthma symptoms [26]. Antidepressant treatment had been found to potentially improve hypertension and asthma control [27, 28]. Therefore, awareness, treatment, and control of depression might be of value in the management of asthma [29].

Comorbid depression was common with immune-mediated inflammatory diseases due to shared pathophysiological mechanisms between the brain and peripheral immune and molecular responses [30]. Raised peripheral cytokines and chemokines (inter-leukin-1β [IL-1β], IL6, C-reactive protein [CRP], tumor necrosis factor-α [TNFα], CXCR3, and CXCL10) due to rheumatoid arthritis might change the immune status and function of the central nervous system via humoral and neuronal routes of communication [31]. It was shown that depression was the most frequent comorbidity in the rheumatoid arthritis population and it would worsen joint pain and disease activity [32, 33]. It was worth encouraging healthcare providers to screen asthmatic individuals with arthritis for depression.

In our study, we further examined whether age and education could be used to identify which asthmatic individuals were at increased risk of depression. We found that higher education was associated with a decreased risk of depression. Higher education had higher resilience in regard to strain and stresses, which might protect against depression and anxiety [34]. In addition, a low education level most often had poorer employment outcomes in adulthood, hence facing a lot of mental and physical health conditions [35]. Increasing age had also been found to be associated with a decreased depression risk (OR 0.97, 95% CI 0.95–0.99). However, this result should be interpreted carefully because the OR value and 95% CI are very close to 1. There was no clear reason why older people were more likely to develop depression. One possibility was that older people accepted the inevitability of physical illness more readily than younger people, leading to a buffer against the adverse effects of physical illness on depression [36]. Lower educational levels and younger age were also considered as risk factors for asthma [37]. Therefore, both lower educational levels and younger age were not only risk factors for asthma but also risk factors for depression in asthma. These findings did suggest that screening for depression in asthmatic individuals with lower education and younger age was necessary.

The strengths of the present study included the use of a nationally representative sample from the NHANES and the exploration of numerous potential factors pertaining to depression. Our study also had several limitations. First, as ours was a cross-sectional study, we could not confirm the direction of relationships between depression, smoking, hypertension, arthritis educational level, age, and other variables. Second, other potential covariates, such as asthma control and drug use, that could be related to depression were not collected in NHANES and therefore were not considered in our analysis. Thus, our findings should be interpreted with caution in that residual confounding could not be excluded. Lastly, many variables in this study were defined by self-reported physician diagnosis. Self-reported data were less accurate than objective records and subject to recall bias, which might limit the reliability of our results. Nonetheless, to the best of my knowledge, our study is the first to explore risk factors for depression in asthma, which might assist clinicians in identifying depression in asthmatic patients.

Conclusions

Depression was more likely in asthmatic individuals with smoking, hypertension, and arthritis, and less likely in individuals with higher education and increasing age. These findings might assist clinicians in identifying depression in asthmatic patients.

Citation: Yang H, Lin P, Liang Z (2023) Risk factors for depression in asthmatic individuals: Findings from NHANES (2005–2018). PLoS ONE 18(6): e0287336. https://doi.org/10.1371/journal.pone.0287336

About the Authors:

Huan Yang

Roles: Conceptualization, Data curation, Formal analysis, Investigation, Methodology, Visualization, Writing – original draft, Writing – review & editing

Affiliation: Department of Respiratory and Critical Care Medicine, West China School of Medicine and West China Hospital, Sichuan University, Chengdu, China

ORICD: https://orcid.org/0000-0002-3502-9490

Ping Lin

Roles: Conceptualization, Data curation, Formal analysis, Investigation, Methodology, Visualization, Writing – original draft, Writing – review & editing

Affiliation: Department of Respiratory and Critical Care Medicine, West China School of Medicine and West China Hospital, Sichuan University, Chengdu, China

Zongan Liang

Roles: Writing – review & editing

E-mail: [email protected]

Affiliation: Department of Respiratory and Critical Care Medicine, West China School of Medicine and West China Hospital, Sichuan University, Chengdu, China

ORICD: https://orcid.org/0000-0002-8358-9177

References

1. Centers for Disease Control and Prevention (CDC). Asthma—United States, 1982–1992. MMWR Morb Mortal Wkly Rep. 1995;43: 952–955. pmid:7799908

2. Fergeson JE, Patel SS, Lockey RF. Acute asthma, prognosis, and treatment. J Allergy Clin Immunol. 2017;139: 438–447. pmid:27554811

3. Nunes C, Pereira AM, Morais-Almeida M. Asthma costs and social impact. Asthma Res Pract. 2017;3: 1. pmid:28078100

4. Chen W, Lynd LD, FitzGerald JM, Marra CA, Balshaw R, To T, et al. Excess medical costs in patients with asthma and the role of comorbidity. Eur Respir J. 2016;48: 1584–1592. pmid:27824603

5. WHO. Depression. https://www.who.int/health-topics/depression

6. Choi G-S, Shin YS, Kim J-H, Choi SY, Lee S-K, Nam Y-H, et al. Prevalence and risk factors for depression in Korean adult patients with asthma: is there a difference between elderly and non-elderly patients? J Korean Med Sci. 2014;29: 1626–1631. pmid:25469061

7. Ciprandi G, Schiavetti I, Rindone E, Ricciardolo FLM. The impact of anxiety and depression on outpatients with asthma. Ann Allergy Asthma Immunol. 2015;115: 408–414. pmid:26392047

8. Urrutia I, Aguirre U, Pascual S, Esteban C, Ballaz A, Arrizubieta I, et al. Impact of anxiety and depression on disease control and quality of life in asthma patients. J Asthma. 2012;49: 201–208. pmid:22308974

9. Lin P, Li X, Liang Z, Wang T. Association between depression and mortality in persons with asthma: a population-based cohort study. Allergy Asthma Clin Immunol. 2022;18: 29. pmid:35365240

10. Brown ES, Vigil L, Khan DA, Liggin JDM, Carmody TJ, Rush AJ. A randomized trial of citalopram versus placebo in outpatients with asthma and major depressive disorder: a proof of concept study. Biol Psychiatry. 2005;58: 865–870. pmid:15993860

11. Centers for Disease Control and Prevention (CDC). About the National Health and Nutrition Examination Survey. Examination Survey. 2017. https://www.cdc.gov/nchs/nhanes/about_nhanes.htm.

12. Amaral R, Pereira AM, Jacinto T, Malinovschi A, Janson C, Alving K, et al. Comparison of hypothesis- and data-driven asthma phenotypes in NHANES 2007–2012: the importance of comprehensive data availability. Clin Transl Allergy. 2019;9: 17. pmid:30918624

13. Kroenke K, Spitzer RL, Williams JB. The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med. 2001;16: 606–613. pmid:11556941

14. Goodchild M, Nargis N, Tursan d’Espaignet E. Global economic cost of smoking-attributable diseases. Tob Control. 2018;27: 58–64. pmid:28138063

15. Foulds J, Ramstrom L, Burke M, Fagerström K. Effect of smokeless tobacco (snus) on smoking and public health in Sweden. Tob Control. 2003;12: 349–359. pmid:14660766

16. Prochaska JJ, Das S, Young-Wolff KC. Smoking, Mental Illness, and Public Health. Annu Rev Public Health. 2017;38: 165–185. pmid:27992725

17. Moylan S, Jacka FN, Pasco JA, Berk M. How cigarette smoking may increase the risk of anxiety symptoms and anxiety disorders: a critical review of biological pathways. Brain Behav. 2013;3: 302–326. pmid:23785661

18. Di Marco F, Santus P, Centanni S. Anxiety and depression in asthma. Curr Opin Pulm Med. 2011;17: 39–44. pmid:20975562

19. H A, DB D, B W, G E, S H, V C, et al. Smoking in young people with asthma. Journal of public health (Oxford, England). 2007;29. pmid:17675644

20. McClave AK, Dube SR, Strine TW, Kroenke K, Caraballo RS, Mokdad AH. Associations between smoking cessation and anxiety and depression among U.S. adults. Addict Behav. 2009;34: 491–497. pmid:19217720

21. Moosey MJ. Effects of Nicotine and Stress on Anxiety-related and Depression-related Behavior in Rats. [cited 18 Feb 2023]. https://apps.dtic.mil/sti/citations/AD1012849

22. L G-F, E M-C, S A-N, Jm G-L, Lm G-R, Ja A-F. Hypertension as a risk factor for developing depressive symptoms among community-dwelling elders. Revista de investigacion clinica; organo del Hospital de Enfermedades de la Nutricion. 2009;61. https://pubmed.ncbi.nlm.nih.gov/19848303/

23. Meng L, Chen D, Yang Y, Zheng Y, Hui R. Depression increases the risk of hypertension incidence: a meta-analysis of prospective cohort studies. J Hypertens. 2012;30: 842–851. pmid:22343537

24. Martinac M, Pehar D, Karlović D, Babić D, Marcinko D, Jakovljević M. Metabolic syndrome, activity of the hypothalamic-pituitary-adrenal axis and inflammatory mediators in depressive disorder. Acta Clin Croat. 2014;53: 55–71. pmid:24974667

25. Yanai H, Tomono Y, Ito K, Furutani N, Yoshida H, Tada N. The underlying mechanisms for development of hypertension in the metabolic syndrome. Nutr J. 2008;7: 10. pmid:18416854

26. Christiansen SC, Schatz M, Yang S-J, Ngor E, Chen W, Zuraw BL. Hypertension and Asthma: A Comorbid Relationship. J Allergy Clin Immunol Pract. 2016;4: 76–81. pmid:26342745

27. Fu W, Ma L, Zhao X, Li Y, Zhu H, Yang W, et al. Antidepressant medication can improve hypertension in elderly patients with depression. J Clin Neurosci. 2015;22: 1911–1915. pmid:26256065

28. Breeden M, Gillis A, Salas J, Scherrer JF. Antidepressant treatment and blood pressure control in patients with comorbid depression and treatment resistant hypertension. J Psychosom Res. 2022;153: 110692. pmid:34906849

29. Christiansen SC, Zuraw BL. Treatment of Hypertension in Patients with Asthma. N Engl J Med. 2019;381: 1046–1057. pmid:31509675

30. Kojima M, Kojima T, Waguri-Nagaya Y, Takahashi N, Asai S, Sobue Y, et al. Depression, physical function, and disease activity associated with frailty in patients with rheumatoid arthritis. Mod Rheumatol. 2021;31: 979–986. pmid:33066713

31. Nerurkar L, Siebert S, McInnes IB, Cavanagh J. Rheumatoid arthritis and depression: an inflammatory perspective. Lancet Psychiatry. 2019;6: 164–173. pmid:30366684

32. Fakra E, Marotte H. Rheumatoid arthritis and depression. Joint Bone Spine. 2021;88: 105200. pmid:33932572

33. Matcham F, Ali S, Irving K, Hotopf M, Chalder T. Are depression and anxiety associated with disease activity in rheumatoid arthritis? A prospective study. BMC Musculoskelet Disord. 2016;17: 155. pmid:27068100

34. Bjelland I, Krokstad S, Mykletun A, Dahl AA, Tell GS, Tambs K. Does a higher educational level protect against anxiety and depression? The HUNT study. Soc Sci Med. 2008;66: 1334–1345. pmid:18234406

35. Hale DR, Bevilacqua L, Viner RM. Adolescent Health and Adult Education and Employment: A Systematic Review. Pediatrics. 2015;136: 128–140. pmid:26101362

36. Kessler RC, Birnbaum H, Bromet E, Hwang I, Sampson N, Shahly V. Age differences in major depression: results from the National Comorbidity Survey Replication (NCS-R). Psychol Med. 2010;40: 225–237. pmid:19531277

37. Ellison-Loschmann L, Sunyer J, Plana E, Pearce N, Zock J-P, Jarvis D, et al. Socioeconomic status, asthma and chronic bronchitis in a large community-based study. Eur Respir J. 2007;29: 897–905. pmid:17215316